Yang, Ming-Han <br/><br/>
PI3K inhibitor provides durable response in metastatic metaplastic carcinoma of the breast: A hidden gem in the BELLE-4 study.  [electronic resource] 

 -  Journal of the Formosan Medical Association = Taiwan yi zhi  Sep 2019 
 - 1333-1338 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>0929-6646 
<br/><br/><label>Standard No.: </label>10.1016/j.jfma.2018.12.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged, 80 and over<br/>Aminopyridines--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Breast Neoplasms--drug therapy<br/>Carcinoma--drug therapy<br/>Female<br/>Humans<br/>Metaplasia--pathology<br/>Morpholines--administration & dosage<br/>Paclitaxel--administration & dosage<br/>Phosphoinositide-3 Kinase Inhibitors--therapeutic use<br/>Randomized Controlled Trials as Topic<br/>Tomography, X-Ray Computed<br/>Treatment Outcome